Truth-telling Statistics that Big Pharma and the CDC Never Report to us Physicians or our Patients

Duty to Warn

 By Gary G. Kohls, MD – May 15, 2018

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

 

The NNV (Number Needed to Vaccinate) and the NNT (Number Needed to Treat):  Truth-telling Statistics that Big Pharma and the CDC Never Report to us Physicians or our Patients

It has been over a decade since I came to the realization that the entire profession of medicine had been bamboozled by the propaganda coming from the Big Pharma drug and vaccine maker Merck & Company that its so-called “fracture-preventative” drug Fosamax had defrauded us doctors and our patients by falsely claiming a “50% efficacy rate” in the prevention of bone fractures in osteopenic/osteoporotic women.

I had always been suspicious of pharmaceutical sales reps and the Big Pharma corporations that they worked for, and I had wondered exactly where they got the 50% effectiveness figure. So I finally got around to actually digging into and studying the clinical study statistics that were in the FDA-approved product insert that all drug and vaccine makers are forced to publish and include with the product (and which only a few physicians ever take the time or inclination to read).

Lying buried among the large number of boring statistical verbiage were printed the numbers that revealed that the 50% efficacy rate for osteopenic patients who took Fosamax for 4 years was actually a deceptive relative risk reduction (RRR) figure that drastically deceptively over-stated the effectiveness of the drug.

By doing a little math I understood that the honest truth of the matter was that patients who took the drug for 4 years had a miniscule 1-2% absolute risk reduction (AAR) in the incidence of fractures, which is a much more realistic figure that Merck, being a sociopathic entity that is inclined to tell half-truths or outright lies, chose not to use in its advertisements.

Are Vaccines Worth The US $300 Billion Autism Is Costing the USA Every Year?

by ChildHealthSafety

A new study published in the Journal of the American Medical Association Pediatrics claims the costs in the US of caring for individuals with the highest needs are $2.4m for each and every individual.  This also does not include those who do not have the highest needs, so the effect of less severe autistic conditions is not included. 

Autism costs the UK at least £32bn a year in terms of treatment, lost earnings, and care and support for children and adults with ASD, according to the study.  This compares with £12bn for cancer, £8bn for heart disease and £5bn for stroke: Autism costs ‘£32bn per year’ in UK9 June 2014By Helen BriggsHealth reporter, BBC News.

With roughly 5 1/2 times the UK population and very broadly similar rates of autistic conditions the annual cost in the US will be in the region very approximately of US $300 billion annually. 

And for those who do not accept vaccines cause autistic conditions: Vaccination Causes Autism – Say US Government & Merck’s Director of Vaccines.